
ByHeart made infant formula for about three and a half years. Production started on March 23, 2022. Everything it ever made was recalled in November 2025.
In that short life, parents told ByHeart about a lot of sick babies.
In one eleven-month stretch, from April 26, 2024 to March 14, 2025, ByHeart received 3,247 complaints. Two-thirds of them, 2,167, were about a baby’s health. That is about six or seven health complaints every day, from a company with roughly 1 percent of the U.S. formula market. (March 2025 FDA Inspection Report, p. 4.)
One of those complaints, on December 22, 2024, was a baby in the hospital with suspected botulism.
And through all of it, ByHeart’s co-founders, President Mia Funt and CEO Ron Belldegrun, kept doing what they did best. They marketed.
I wrote last week about the complaints ByHeart closed. This post puts those complaints side by side with what ByHeart and its founders were telling parents at the same time.
Salmonella. Campylobacter. E. coli.
Of the 2,167 health complaints in that window, ByHeart sent only 69 to BlendHouse Portland, the Oregon plant that filled every can and every stick pack. It called ten of those “sensitive.” The FDA investigator listed all ten. (March 2025 EIR, pp. 4–6.)
A daughter diagnosed with Salmonella.
A baby with a Salmonella infection that had entered the bloodstream.
Diaper rash and diarrhea, then Campylobacter in the stool.
Two more babies with stool positive for Salmonella.
A baby who got Salmonella after drinking two batches of ByHeart. ByHeart opened two investigations, one per batch.
Mucous, diarrhea and blood, with cultures confirming Salmonella.
Two weeks of diarrhea, positive for E. coli.
Diarrhea, a high fever, and blood and mucous in the stool, diagnosed as Salmonella.
Eight Salmonella files. One Campylobacter. One E. coli.
Every investigation ended the same way: no evidence the batch was contaminated, and all process controls effective.
Then ByHeart told the FDA it never received more than one sensitive complaint on any single batch. Of course it didn’t. It counted one batch at a time. When one sick baby drank two batches, that became two complaints of one each. A system built that way never puts two sick babies on the same page.
The Botulism Complaint
On December 22, 2024, a parent reported a hospitalized baby with suspected Clostridium botulinum. (November 2025 FDA Inspection Report, pp. 4, 7–8.)
ByHeart never got a lot number. It marked the complaint lost to follow-up. That is the entire record.
Nothing in the FDA’s files shows ByHeart called the hospital, called California’s Infant Botulism Treatment and Prevention Program, pulled retained samples and tested them for C. botulinum, or told the FDA.
Three months later, the FDA inspected Portland and reviewed ByHeart’s complaints for exactly the period that included December 22. The botulism complaint was not among the ten “sensitive” complaints ByHeart showed the investigator. The word botulism does not appear in that report.
When the FDA came back in November 2025 for the outbreak, Portland’s Director of Quality said the company had only ever received one complaint of a hospitalized baby with suspected botulism. One. As if that were reassuring.
Infant botulism is rare. Before ByHeart, no outbreak of it had ever been tied to infant formula. A parent calling a formula company to say the doctors think my baby has botulism is not a routine complaint. It is a fire alarm.
I have done this work for more than thirty years. When a parent reports a hospitalized baby with suspected botulism, a responsible formula company calls back until it reaches the family. It calls the hospital. It calls the health department and California’s infant botulism program. It pulls its retained samples from every lot that baby could have been fed and sends them to a lab that can find C. botulinum. It tells the FDA. And it puts that complaint in front of the next FDA investigator who walks in the door.
ByHeart wrote lost to follow-up.
It Started Before That
ByHeart’s trouble did not begin in 2024.
In August 2022, five months into production, a base mix made at ByHeart’s own plant tested positive for Cronobacter sakazakii. In October 2022, a finished batch tested positive. ByHeart first blamed the lab. The lab was right. (FDA Warning Letter.) In December 2022, ByHeart recalled five batches.
On August 30, 2023, the FDA sent ByHeart a warning letter for failing to have process controls covering every stage of production to keep microbes out of baby formula. (FDA Warning Letter.) That winter, FDA found a moldy water tank, a leaking roof and dead insects at the Reading, Pennsylvania plant. (Food Safety Magazine.)
Between July 31, 2023 and April 23, 2024, ByHeart logged three “serious” health complaints. All three babies were hospitalized. ByHeart called all three allergies. (April 2024 FDA Inspection Report, p. 4.)
The first baby in the botulism outbreak got sick on December 24, 2023. (FDA CORE file, FOIA 2026-4033.)
What Mia and Ron Were Saying
Now listen to the other side of the conversation, much of it in the founders’ own words, on video that we saved.
In June 2021, before the first can shipped, Belldegrun explained the his philosophy: “the more you control of the process, the more you control the quality of the formula.” At the March 2022 launch, Funt said ByHeart had “sourced every ingredient, and applied rigorous quality standards, from farm to formula.”
In August 2023, ByHeart hit Target shelves nationwide and announced it was the first U.S.-made formula to win the Clean Label Project’s Purity Award. The FDA warning letter came eight days later. ByHeart’s Target page kept telling parents about its “meticulous safety and quality standards every step of the way.”
On November 8, 2023, ten weeks after the warning letter, Funt told parents in a video that “the ingredients are tested before they even ever enter the facility.” None of that testing was for C. botulinum. Six weeks later, the first baby in the outbreak got sick.
On March 21, 2025, three months after the botulism complaint, and the same week FDA investigators were inside the Portland plant, Funt told parents ByHeart ran “over a thousand tests on our ingredients and throughout every step of the process.” Not one of those thousand tests was for C. botulinum.
On May 13, 2025, ByHeart launched the Anywhere Pack, single-serve stick packs for feeding on the go. Funt said “today’s parents aren’t putting their lives on pause when they have children.” Belldegrun touted the patented protein blend. To celebrate, ByHeart gave away a chance at one million airline miles to babies born between January and May 2025, and bragged that its retail footprint had grown more than 200 percent in a year.
In June 2025, Belldegrun wrote an op-ed urging formula makers to “build their own supply chains, and offer traceability,” and told parents that they “directly handpick[s] all of our ingredients.”
The influencer ads, as Kristin Beck wrote in Food Safety News, showed mother after mother mixing ByHeart with bottled or tap water in the park, in the car, on the sidewalk. Powdered formula is not sterile. Some of those ads were still running on Instagram after the recall.
On October 6, 2025, ByHeart rolled out a celebrity campaign with Lance Bass, Mayci Neely and Trae Young, under the banner “Certified-Clean & High Standards,” in nearly 12,000 stores. “We’re a company for parents, by parents,” Funt said.
By then, babies were already in the hospital. The main cluster of the outbreak began on August 9, 2025. And parents were calling about the two lots that would be recalled first. One said a pediatrician confirmed ByHeart caused her baby’s constipation. It went away when the baby came off ByHeart and came back when ByHeart was restarted. The FDA’s entry reads: “No root cause analysis was conducted.” Another reported a colicky, constipated baby with a swollen belly. Lost to follow-up. (November 2025 EIR, p. 4.)
Constipation is usually the first sign of infant botulism.
After the FDA Called
On November 7, 2025, the FDA told ByHeart that 13 babies with botulism had been fed its formula. The next day ByHeart recalled two lots and told the public: “No ByHeart product has tested positive for any contaminants.”
That was not true. ByHeart’s own finished product tested positive for Cronobacter sakazakii in 2022, and ByHeart recalled it.
Then Funt went on Instagram. “There is no reason to believe that infant formula can cause infant botulism,” she told parents. In a TikTok video she said “multiple regulatory bodies such as Codex have come to this conclusion.” The Codex Committee on Food Hygiene had in fact listed C. botulinum as a pathogen of concern in powdered infant formula. ByHeart later deleted the TikTok video.
On November 9, the founders signed a letter to families, “Mia & Ron, ByHeart Co-Founders,” saying “no U.S. or global infant formula company tests for Clostridium botulinum.” By then, the California Department of Public Health had already found C. botulinum in an opened can of ByHeart fed to a baby with botulism. The founders also told parents no one had found it in an unopened can. (McGraw Hill summary.) New York’s Wadsworth Center later did, in an unopened can from Arizona. (Marler Blog on the FDA file.)
On November 11, ByHeart recalled everything it had ever made. That same day, it posted on Instagram recommending Nara Organics formula to its customers, with a 20 percent discount code. Nara would have its own botulism outbreak in 2026, from the same milk supplier. ByHeart deleted that post too.
Then came refunds. ByHeart offered them only on purchases from August 1, 2025 on, and explained that it had acted “despite the initial notification to ByHeart on November 7, 2025.”
Initial notification. ByHeart was told about a hospitalized baby with suspected botulism on December 22, 2024. Parents complained on ByHeart’s Instagram about waiting weeks for even those refunds.
What It Adds Up To
The final count: 48 babies in 17 states, sick from December 24, 2023 to November 29, 2025. Every one hospitalized. Every one treated with BabyBIG. The FDA never found a root cause. (FDA CORE file.)
ByHeart never tested for C. botulinum before the outbreak. Its Portland food safety plan did not identify any biological hazard in the ingredients it received. (March 2025 EIR, pp. 18–19.) The U.S. Senate HELP Committee wrote to Belldegrun and Funt by name in December 2025. And now the two of them run MeridianMade, which has agreed to buy Perrigo’s infant formula business.
Here is the whole story in two columns.
On one side: thousands of health complaints. Babies with Salmonella in their blood. Campylobacter. E. coli. Three hospitalized babies called allergies. A botulism report closed as lost to follow-up.
On the other: farm to formula, a thousand tests, handpicked ingredients, certified clean, a million airline miles, celebrities, and, once babies were in the hospital, “no reason to believe that infant formula can cause infant botulism.”
Complaint systems exist for one reason: to hear the warning before the outbreak. Parents were warning ByHeart. Mia Funt and Ron Belldegrun kept selling.
That is why I keep pushing for a rule requiring C. botulinum testing of powdered infant formula and its dairy ingredients. Parents should not have to depend on whether a company is listening.
Sources
FDA, Clostridium botulinum/Infant Formula/Nov 2025 – CARA ID 1350: https://www.fda.gov/media/192722/download
FDA, Establishment Inspection Report, BlendHouse Portland (Apr. 22–26, 2024): https://www.marlerblog.com/files/2026/11/2-2024-04-26-Portland-EIR-2024-04-22-to-04-26-FEI-3013670080.pdf
FDA, Establishment Inspection Report Amendment 1, BlendHouse Portland (Mar. 17–27, 2025): https://www.marlerblog.com/files/2026/11/4-2025-03-27-Portland-EIR-2025-03-17-to-03-27-Amend-1-FEI-3013670080.pdf
FDA, Establishment Inspection Report Amendment 1, BlendHouse Portland (Nov. 11, 2025 – Jan. 23, 2026): https://www.marlerblog.com/files/2026/11/1-final_applied_blendhouse_portland_or_3013670080_eir_11-11-25_-1-23-26_amendment_1_br_nj_vlo.508.pdf
FDA, Warning Letter to ByHeart, Inc., MARCS-CMS 653854 (Aug. 30, 2023): https://www.marlerblog.com/files/2025/11/Reading-Warning-ByHeart-Inc.-653854-08302023-FDA.pdf
ByHeart, Voluntary Recall of Five Batches (Dec. 2022), posted by FDA: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/byheart-issues-voluntary-recall-five-batches-its-infant-formula-because-possible-health-risk
FDA CORE records, FOIA Request No. 2026-4033 (redacted): https://www.marlerblog.com/files/2026/08/FOIA-2026-4033_Redacted.pdf
Marler Blog, Eleven Months Early: ByHeart’s Botulism Complaint (Nov. 20, 2026): https://www.marlerblog.com/case-news/eleven-months-early-byhearts-botulism-complaint-and-all-the-other-sick-baby-complaints-it-closed/
Marler Blog, FDA’s Own ByHeart Botulism File (Aug. 31, 2026): https://www.marlerblog.com/case-news/fdas-own-byheart-botulism-file-48-babies-17-strains-a-death-complaint-no-root-cause-and-six-company-names-blacked-out/
Food Safety Magazine, ByHeart Finds Widespread Contamination; FDA Publishes Inspection Reports: https://www.food-safety.com/articles/10905-byheart-finds-widespread-contamination-in-infant-formula-as-botulism-outbreak-grows-fda-publishes-inspection-reports
Nutrition Insight, ByHeart brings protein-enhanced infant formula to US market (Mar. 24, 2022): https://www.nutritioninsight.com/news/byheart-brings-protein-enhanced-infant-formula-from-scratch-to-us-market.html
Nutritional Outlook, ByHeart makes retail debut at Target (Aug. 22, 2023): https://nutritionaloutlook.com/view/byheart-infant-formula-makes-retail-debut-at-target-locations-nationwide
Target, ByHeart Whole Nutrition Infant Formula product page: https://www.target.com/p/-/A-87956594
Business Wire, ByHeart Launches Anywhere Pack (May 13, 2025): https://www.businesswire.com/news/home/20250513513492/en
Business Wire, ByHeart campaign with Lance Bass, Mayci Neely and Trae Young (Oct. 6, 2025): https://www.businesswire.com/news/home/20251006647323/en
Food Safety News, Years before outbreak, ByHeart’s marketing encouraged dangerous practices (Jan. 28, 2026): https://www.foodsafetynews.com/2026/01/years-before-outbreak-byhearts-marketing-encouraged-dangerous-practices/
ByHeart influencer reel, Instagram: https://www.instagram.com/reel/DN3cpuvQBFY/
ByHeart, Voluntary Recall of Two Batches (Nov. 8, 2025), via Oregon Dept. of Agriculture: https://apps.oregon.gov/oregon-newsroom/OR/ODA/Posts/Post/In-Response-to-a-Broader-FDA-Investigation-ByHeart-Initiates-a-Voluntary-Recall-of-Two-Batches-of-Infant-Formula
McGraw Hill, Infants Hospitalized after Baby Formula Recall (Dec. 2025): https://www.mheducation.com/highered/blog/2025/12/infants-hospitalized-after-baby-formula-recall
ABC News, CDC says 51 infants hospitalized in botulism outbreak: https://abcnews.go.com/family/story/cdc-2-infants-hospitalized-botulism-outbreak-byheart-expands-127417947
Consumer Reports, ByHeart recall expanded to all formula ever produced: https://consumerreports.org/babies-kids/baby-product-recalls/byheart-formula-recall-expanded-infant-botulism-a2906529472/
MedicineNet, FDA links ByHeart outbreak to milk powder ingredient: https://www.medicinenet.com/fda_byheart_baby_formula_outbreak_milk_powder/news.htm
U.S. Senate HELP Committee, Letter to ByHeart (Dec. 18, 2025): https://www.help.senate.gov/imo/media/doc/letter_to_byheart_on_infant_formula_recall.pdf
ByHeart and founders’ videos and posts: Belldegrun (June 2021; June 2025 op-ed and video); Funt (Mar. 2022 launch; Nov. 8, 2023; Mar. 21, 2025; Instagram and TikTok, Nov. 2025); “Mia & Ron” letter (Nov. 9, 2025); Nara Instagram post (Nov. 11, 2025):
Boursorama/Reuters, Perrigo to sell infant formula business to MeridianMade: https://www.boursorama.com/bourse/actualites/perrigo-va-ceder-son-activite-de-lait-infantile-a-meridianmade-pour-un-montant-pouvant-atteindre-175-millions-de-dollars-a97ddb1ee25f905b63f75389a68db0f1











